canatpeptide
KS-V Peptide offer comprehensive support for integrated drug discovery and development services
Novel Drug Approvals for 2023
In 2023, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) hit a significant milestone, approving 55 new drugs, an increase of nearly 50% from last year and second only to the all-time high of 2018 .
- できごと(0)
- by canatpeptide
- at 2024/01/19 10:30
できごとへのコメント